Rapamycin treatment induces tubular proteinuria: role of megalin-mediated protein reabsorption

Rapamycin treatment induces tubular proteinuria: role of megalin-mediated protein reabsorption

Introduction: Rapamycin is an immunosuppressor that acts by inhibiting the serine/threonine kinase mechanistic target of rapamycin complex 1. Therapeutic use of rapamycin is limited by its adverse effects. Proteinuria is an important marker of kidney damage and a risk factor for kidney diseases prog...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Rodrigo A. S. Peres, Diogo B. Peruchetti, Rodrigo P. Silva-Aguiar, Douglas E. Teixeira, Carlos P. Gomes, Christina M. Takiya, Ana Acacia S. Pinheiro, Celso Caruso-Neves
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Frontiers Media S.A. 2023-07-01
Sarja:Frontiers in Pharmacology
Aiheet:
rapamycin
proximal tubule
megalin
protein reabsorption
proteinuria
Linkit:https://www.frontiersin.org/articles/10.3389/fphar.2023.1194816/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1194816/full

Samankaltaisia teoksia